Amount Raised
$32 Million
Description
Chinese synthetic biology firm Shenzhen Siyomicro Biotech has raised nearly 200 million yuan ($31.7 million) in a Series B round of financing led by CICC’s flagship private equity (PE) platform CICC Capital.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech